-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
-
Summary
-
Biolife Solutions Inc quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate from Q1 2021 to Q1 2024.
- Biolife Solutions Inc Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $5K, a 61.5% decline year-over-year.
- Biolife Solutions Inc annual Deferred Income Tax Expense (Benefit) for 2023 was -$62K, a 98.8% increase from 2022.
- Biolife Solutions Inc annual Deferred Income Tax Expense (Benefit) for 2022 was -$5.24M, a 74% increase from 2021.
- Biolife Solutions Inc annual Deferred Income Tax Expense (Benefit) for 2021 was -$20.1M, a 510% decline from 2020.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Deferred Income Tax Expense (Benefit), YoY Quarterly Growth (%)